Label Image (Lbl530026624)
Losartan Potassium
Product Images NDC 53002-6624
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-6624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Fig1)
Figure 2 (Losartan Fig2)
This text appears to be discussing the percentage of patients with fatal/non-fatal strokes in relation to the use of two medications, Atenolol and Losartan Potassium Tablets. It states that there is an adjusted risk reduction of 25% with a statistical significance of p=0.001. The text also mentions different study months, implying that these medications were evaluated over a period of time.*
Figure 3 (Losartan Fig3)
Figure 4 (Losartan Fig4)
This text appears to be a report or evaluation of a study involving patients and the medication "Losartan Potassium Tablets" compared to a placebo. It provides information about the percentage of patients who experienced an event, a risk reduction percentage of 16.1%, and a p-value of 0.022. There are also numerical values ranging from 0 to 48, possibly representing a time period. The purpose or specific details of the study are not clear from this text.*
Losartan-str.jpg (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
